JP2021501133A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021501133A5 JP2021501133A5 JP2020520812A JP2020520812A JP2021501133A5 JP 2021501133 A5 JP2021501133 A5 JP 2021501133A5 JP 2020520812 A JP2020520812 A JP 2020520812A JP 2020520812 A JP2020520812 A JP 2020520812A JP 2021501133 A5 JP2021501133 A5 JP 2021501133A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- formula
- alkyl groups
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 8
- 239000002537 cosmetic Substances 0.000 claims 6
- -1 (1H-indole-3-yl) methyl Chemical group 0.000 claims 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 4
- 150000001413 amino acids Chemical group 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 230000036074 healthy skin Effects 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 230000013632 homeostatic process Effects 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 210000004761 scalp Anatomy 0.000 claims 2
- 244000005714 skin microbiome Species 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 claims 1
- OIQXFRANQVWXJF-UHFFFAOYSA-N 2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=CC=C1 OIQXFRANQVWXJF-UHFFFAOYSA-N 0.000 claims 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims 1
- 208000020154 Acnes Diseases 0.000 claims 1
- 244000063299 Bacillus subtilis Species 0.000 claims 1
- 235000014469 Bacillus subtilis Nutrition 0.000 claims 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims 1
- 208000012641 Pigmentation disease Diseases 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 239000004904 UV filter Substances 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 229960005193 avobenzone Drugs 0.000 claims 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims 1
- 229960000655 ensulizole Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 claims 1
- 229960004881 homosalate Drugs 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 claims 1
- 229960001679 octinoxate Drugs 0.000 claims 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims 1
- 229960000601 octocrylene Drugs 0.000 claims 1
- 230000019612 pigmentation Effects 0.000 claims 1
- 229940100498 polysilicone-15 Drugs 0.000 claims 1
- 229920002282 polysilicones-15 Polymers 0.000 claims 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000008591 skin barrier function Effects 0.000 claims 1
- 239000004408 titanium dioxide Substances 0.000 claims 1
- 229960001295 tocopherol Drugs 0.000 claims 1
- 229930003799 tocopherol Natural products 0.000 claims 1
- 235000010384 tocopherol Nutrition 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- 229940042585 tocopherol acetate Drugs 0.000 claims 1
- 239000011787 zinc oxide Substances 0.000 claims 1
- 229960001296 zinc oxide Drugs 0.000 claims 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17199080.7 | 2017-10-30 | ||
| EP17199080 | 2017-10-30 | ||
| PCT/EP2018/079522 WO2019086361A1 (en) | 2017-10-30 | 2018-10-29 | Antimicrobial tetrapeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021501133A JP2021501133A (ja) | 2021-01-14 |
| JP2021501133A5 true JP2021501133A5 (enExample) | 2021-07-26 |
| JP7231307B2 JP7231307B2 (ja) | 2023-03-01 |
Family
ID=60409114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520812A Active JP7231307B2 (ja) | 2017-10-30 | 2018-10-29 | 抗微生物性テトラペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200308222A1 (enExample) |
| EP (1) | EP3704134B1 (enExample) |
| JP (1) | JP7231307B2 (enExample) |
| KR (1) | KR102694657B1 (enExample) |
| CN (1) | CN111278846B (enExample) |
| BR (1) | BR112020008175A2 (enExample) |
| WO (1) | WO2019086361A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025524352A (ja) * | 2022-06-15 | 2025-07-30 | ディーエスエム アイピー アセッツ ビー．ブイ． | にきびの処置のためのｕｖフィルターの使用 |
| WO2025174058A1 (ko) * | 2024-02-15 | 2025-08-21 | (주)뉴트리 | 탈모 유발 유해균에 대한 항균 효과를 갖는 두피 유래 펩타이드 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2466492A1 (en) | 1979-10-03 | 1981-04-10 | Elf Aquitaine | Dyeing keratin substances, e.g. skin, nails, hair, fur - with compsns. contg. ketone or aldehyde dye and sulphoxy-aminoacid |
| FR2651126B1 (fr) | 1989-08-29 | 1991-12-06 | Oreal | Association de dihydroxyacetone et de derives indoliques pour conferer a la peau une coloration similaire au bronzage naturel et procede de mise en óoeuvre. |
| FR2661673B1 (fr) | 1990-05-07 | 1992-08-21 | Oreal | Association de dihydroxyacetone et de monohydroxyindoles pour conferer a la peau une coloration similaire au bronzage naturel, dispositif a plusieurs compartiments et procede de mise en óoeuvre. |
| DE19603018C2 (de) | 1996-01-17 | 1998-02-26 | Lancaster Group Gmbh | Kosmetisches Selbstbräunungsmittel mit Lichtschutzwirkung |
| FR2746391B1 (fr) | 1996-03-22 | 1998-04-17 | Oreal | Compositions cosmetiques a base de pyrazolin-4,5-diones, nouvelles pyrazolin-4,5 diones, procedes de preparation et utilisations |
| FR2761595B1 (fr) | 1997-04-04 | 1999-09-17 | Oreal | Compositions comprenant des santalines, santarubines pour la coloration artificielle de la peau et utilisations |
| FR2768733B1 (fr) | 1997-09-19 | 1999-10-29 | Oreal | Nouveaux composes 4,4-dihydroxypyrazolin-5-ones ; leurs procedes de preparation et utilisations cosmetiques |
| FR2780281B1 (fr) | 1998-06-26 | 2000-08-18 | Oreal | Compositions comprenant des nanopigments d'oxydes de fer pour la coloration artificielle de la peau et utilisations |
| WO2012158960A2 (en) | 2011-05-17 | 2012-11-22 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | Melanocortin 1 receptor ligands and methods of use |
| MX366171B (es) | 2012-11-21 | 2019-07-01 | Univ Cincinnati | Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina. |
-
2018
- 2018-10-29 US US16/759,851 patent/US20200308222A1/en not_active Abandoned
- 2018-10-29 BR BR112020008175-2A patent/BR112020008175A2/pt unknown
- 2018-10-29 KR KR1020207015187A patent/KR102694657B1/ko active Active
- 2018-10-29 JP JP2020520812A patent/JP7231307B2/ja active Active
- 2018-10-29 EP EP18795520.8A patent/EP3704134B1/en active Active
- 2018-10-29 WO PCT/EP2018/079522 patent/WO2019086361A1/en not_active Ceased
- 2018-10-29 CN CN201880070344.6A patent/CN111278846B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018535203A5 (enExample) | ||
| CA2998596C (en) | Sunscreen compositions with improved water resistance of uva and uvb sunscreen active agents | |
| HUE029247T2 (en) | Benzimidazole Respiratory Syncytial Virus Inhibitors | |
| JP2018536641A5 (enExample) | ||
| JP2017521463A (ja) | ビタミンｄの形成のために最適化された日焼け止め製剤 | |
| ATE487720T1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer | |
| ES2984129T3 (es) | Composiciones tópicas | |
| MA45043B1 (fr) | Composés pour stimuler la croissance des cheveux et/ou inhiber ou retarder la chute des cheveux chez l'homme, et compositions pour de telles utilisations | |
| JP6887895B2 (ja) | 外用組成物 | |
| JP2021501133A5 (enExample) | ||
| WO2019171385A1 (en) | Preservation of personal care compositions | |
| CN104080437A (zh) | 用于光稳定丁基甲氧基二苯甲酰基甲烷(bmdbm)的防晒剂的组合物和组合 | |
| JP2025133982A (ja) | 油中水型乳化日焼け止め化粧料 | |
| JP2004168781A (ja) | 多孔質シリカの球状微小粒子をベースにしたサンタン加圧装置 | |
| JP6739153B2 (ja) | 疎水性変性イヌリン及びポリエーテル変性シリコーンを含む組成物 | |
| JP2020203888A (ja) | 化粧品製剤におけるｕｖフィルター用可溶化剤 | |
| AU2015312014B2 (en) | Mineral sunscreen compositions | |
| JP2019108325A (ja) | 保存増強剤 | |
| ES2911191T3 (es) | Composición cosmética para una rápida evaporación del sudor | |
| BR112020012422B1 (pt) | Composição tópica, uso relacionado e método para reduzir a transferência de gordura ou óleo para uma superfície | |
| US11534374B2 (en) | Topical composition | |
| EP2482793B1 (en) | Use of piperidine ester derivative as solvent in cosmetic compositions; cosmetic compositions comprising it | |
| WO2016119028A1 (en) | Transparent sunscreen composition | |
| JP2015063485A (ja) | 外用組成物 | |
| US20120269749A1 (en) | Cosmetic compositions comprising an ester derived from 4-carboxy-2-pyrrolidinone and a merocyanin screening agent; use of said derivative as a solvent for a merocyanin screening agent |